US Stock MarketDetailed Quotes

RDY Dr. Reddy's Laboratories

Watchlist
  • 13.555
  • -0.045-0.33%
Trading Feb 18 12:36 ET
11.29BMarket Cap18.29P/E (TTM)

Dr. Reddy's Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
15.85%83.59B
16.51%80.16B
13.54%279.16B
12.49%70.83B
6.57%72.15B
9.11%68.8B
29.20%67.38B
14.69%245.88B
15.82%62.97B
27.26%67.7B
Operating revenue
15.85%83.59B
16.51%80.16B
13.54%279.16B
12.49%70.83B
6.57%72.15B
9.11%68.8B
29.20%67.38B
14.69%245.88B
15.82%62.97B
27.26%67.7B
Cost of revenue
15.32%34.53B
13.92%32.39B
8.47%115.56B
8.81%29.35B
8.47%29.95B
10.17%28.43B
6.44%27.83B
5.95%106.54B
5.25%26.97B
12.29%27.61B
Gross profit
16.23%49.05B
18.33%47.77B
17.41%163.61B
15.24%41.48B
5.26%42.2B
8.38%40.37B
52.09%39.55B
22.40%139.34B
25.24%36B
40.13%40.09B
Operating expense
19.95%30.34B
29.90%29.72B
22.43%98.3B
22.96%28.21B
12.28%25.3B
8.94%22.88B
58.57%21.91B
3.04%80.29B
16.38%22.94B
16.40%22.53B
Selling and administrative expenses
19.23%24.12B
22.41%23.01B
13.49%77.2B
13.81%20.48B
12.50%20.23B
13.50%18.8B
14.26%17.7B
9.58%68.03B
14.79%17.99B
16.68%17.98B
Research and development costs
19.64%6.66B
33.49%7.27B
18.02%22.87B
28.16%6.88B
15.43%5.57B
11.87%5.45B
15.24%4.98B
10.86%19.38B
24.04%5.37B
15.92%4.82B
Other operating expenses
13.10%-431M
59.23%-554M
75.06%-1.78B
302.86%852M
-82.35%-496M
-221.28%-1.36B
87.01%-780M
-333.50%-7.12B
-44.33%-420M
-26.51%-272M
Operating profit
10.66%18.71B
3.20%18.05B
10.59%65.31B
1.68%13.28B
-3.74%16.91B
7.66%17.49B
44.75%17.65B
64.41%59.05B
44.55%13.06B
89.73%17.56B
Net non-operating interest income expense
-160.32%-114M
-125.14%-92M
328.63%567M
-55.00%54M
230.34%189M
493.55%366M
703.08%784M
-3,642.86%-248M
-86.03%120M
-408.51%-145M
Non-operating interest income
20.75%704M
-7.51%665M
93.05%2.28B
36.50%647M
113.55%583M
232.87%719M
----
22.28%1.18B
--474M
4.20%273M
Non-operating interest expense
107.61%818M
114.45%757M
19.82%1.71B
67.51%593M
-5.74%394M
14.24%353M
----
49.06%1.43B
--354M
94.42%418M
Total other finance cost
----
----
----
----
----
----
---784M
----
----
----
Other net income (expense)
-87.26%148M
-5.38%1.21B
284.05%6B
3,431.58%2.68B
208.40%1.16B
3,567.57%1.28B
-98.77%32M
143.03%1.56B
101.03%76M
-364.69%-1.07B
Gain on sale of security
-87.86%94M
91.73%1.65B
10.51%3.43B
42.56%968M
12,800.00%774M
1,463.49%859M
----
46.83%3.1B
--679M
-97.52%6M
Earnings from equity interest
55.56%42M
45.24%61M
-60.27%147M
-53.95%35M
-55.00%27M
-70.00%42M
-54.26%43M
-47.37%370M
-27.62%76M
-67.57%60M
Special income (charges)
-96.68%12M
-229.32%-494M
226.75%2.42B
347.57%1.68B
131.72%361M
435.09%382M
-152.38%-11M
70.36%-1.91B
90.96%-679M
-5,072.73%-1.14B
-Less:Impairment of capital assets
-103.64%-4M
1,580.00%924M
-99.57%3M
-132.04%-173M
-17.91%110M
120.00%55M
--11M
-90.76%699M
-92.81%540M
185.11%134M
-Less:Other special charges
----
----
---1.52B
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
-98.30%8M
-1.60%430M
174.32%900M
88.49%-16M
146.91%471M
591.01%437M
----
-208.22%-1.21B
---139M
-4,116.00%-1B
Income before tax
2.66%18.74B
0.17%19.17B
19.06%71.87B
20.83%16.02B
11.69%18.26B
18.76%19.13B
25.98%18.46B
86.91%60.37B
433.83%13.26B
68.36%16.35B
Income tax
5.28%4.7B
32.72%5.75B
5.79%16.19B
-19.57%2.95B
15.30%4.47B
-13.02%4.33B
59.70%4.44B
75.26%15.3B
127.80%3.66B
46.56%3.88B
Net income
1.81%14.04B
-9.36%13.42B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
Net income continuous Operations
1.81%14.04B
-9.36%13.42B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
Minority interest income
-95M
862M
0
0
Net income attributable to the parent company
2.49%14.13B
-15.18%12.55B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.49%14.13B
-15.18%12.55B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
Basic earnings per share
2.42%16.96
-15.29%3.014
23.29%66.93
36.11%15.732
10.27%16.56
-73.61%3.558
17.92%16.8762
91.04%54.286
996.08%11.558
76.35%15.018
Diluted earnings per share
2.42%16.94
-15.26%3.01
23.32%66.804
36.15%15.706
10.34%16.54
-73.45%3.552
17.96%16.844
91.16%54.17
996.58%11.536
76.44%14.99
Dividend per share
0
7.9746
8.0052
0
0
0
8.0052
0
0
0
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 15.85%83.59B16.51%80.16B13.54%279.16B12.49%70.83B6.57%72.15B9.11%68.8B29.20%67.38B14.69%245.88B15.82%62.97B27.26%67.7B
Operating revenue 15.85%83.59B16.51%80.16B13.54%279.16B12.49%70.83B6.57%72.15B9.11%68.8B29.20%67.38B14.69%245.88B15.82%62.97B27.26%67.7B
Cost of revenue 15.32%34.53B13.92%32.39B8.47%115.56B8.81%29.35B8.47%29.95B10.17%28.43B6.44%27.83B5.95%106.54B5.25%26.97B12.29%27.61B
Gross profit 16.23%49.05B18.33%47.77B17.41%163.61B15.24%41.48B5.26%42.2B8.38%40.37B52.09%39.55B22.40%139.34B25.24%36B40.13%40.09B
Operating expense 19.95%30.34B29.90%29.72B22.43%98.3B22.96%28.21B12.28%25.3B8.94%22.88B58.57%21.91B3.04%80.29B16.38%22.94B16.40%22.53B
Selling and administrative expenses 19.23%24.12B22.41%23.01B13.49%77.2B13.81%20.48B12.50%20.23B13.50%18.8B14.26%17.7B9.58%68.03B14.79%17.99B16.68%17.98B
Research and development costs 19.64%6.66B33.49%7.27B18.02%22.87B28.16%6.88B15.43%5.57B11.87%5.45B15.24%4.98B10.86%19.38B24.04%5.37B15.92%4.82B
Other operating expenses 13.10%-431M59.23%-554M75.06%-1.78B302.86%852M-82.35%-496M-221.28%-1.36B87.01%-780M-333.50%-7.12B-44.33%-420M-26.51%-272M
Operating profit 10.66%18.71B3.20%18.05B10.59%65.31B1.68%13.28B-3.74%16.91B7.66%17.49B44.75%17.65B64.41%59.05B44.55%13.06B89.73%17.56B
Net non-operating interest income expense -160.32%-114M-125.14%-92M328.63%567M-55.00%54M230.34%189M493.55%366M703.08%784M-3,642.86%-248M-86.03%120M-408.51%-145M
Non-operating interest income 20.75%704M-7.51%665M93.05%2.28B36.50%647M113.55%583M232.87%719M----22.28%1.18B--474M4.20%273M
Non-operating interest expense 107.61%818M114.45%757M19.82%1.71B67.51%593M-5.74%394M14.24%353M----49.06%1.43B--354M94.42%418M
Total other finance cost ---------------------------784M------------
Other net income (expense) -87.26%148M-5.38%1.21B284.05%6B3,431.58%2.68B208.40%1.16B3,567.57%1.28B-98.77%32M143.03%1.56B101.03%76M-364.69%-1.07B
Gain on sale of security -87.86%94M91.73%1.65B10.51%3.43B42.56%968M12,800.00%774M1,463.49%859M----46.83%3.1B--679M-97.52%6M
Earnings from equity interest 55.56%42M45.24%61M-60.27%147M-53.95%35M-55.00%27M-70.00%42M-54.26%43M-47.37%370M-27.62%76M-67.57%60M
Special income (charges) -96.68%12M-229.32%-494M226.75%2.42B347.57%1.68B131.72%361M435.09%382M-152.38%-11M70.36%-1.91B90.96%-679M-5,072.73%-1.14B
-Less:Impairment of capital assets -103.64%-4M1,580.00%924M-99.57%3M-132.04%-173M-17.91%110M120.00%55M--11M-90.76%699M-92.81%540M185.11%134M
-Less:Other special charges -----------1.52B----------------------------
-Gain on sale of property,plant,equipment -98.30%8M-1.60%430M174.32%900M88.49%-16M146.91%471M591.01%437M-----208.22%-1.21B---139M-4,116.00%-1B
Income before tax 2.66%18.74B0.17%19.17B19.06%71.87B20.83%16.02B11.69%18.26B18.76%19.13B25.98%18.46B86.91%60.37B433.83%13.26B68.36%16.35B
Income tax 5.28%4.7B32.72%5.75B5.79%16.19B-19.57%2.95B15.30%4.47B-13.02%4.33B59.70%4.44B75.26%15.3B127.80%3.66B46.56%3.88B
Net income 1.81%14.04B-9.36%13.42B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B
Net income continuous Operations 1.81%14.04B-9.36%13.42B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B
Minority interest income -95M862M00
Net income attributable to the parent company 2.49%14.13B-15.18%12.55B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.49%14.13B-15.18%12.55B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B
Basic earnings per share 2.42%16.96-15.29%3.01423.29%66.9336.11%15.73210.27%16.56-73.61%3.55817.92%16.876291.04%54.286996.08%11.55876.35%15.018
Diluted earnings per share 2.42%16.94-15.26%3.0123.32%66.80436.15%15.70610.34%16.54-73.45%3.55217.96%16.84491.16%54.17996.58%11.53676.44%14.99
Dividend per share 07.97468.00520008.0052000
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call